Conference Summaries: Day Four<BR> Thursday, February 28, 2002

The Body Covers: The 9th Conference on Retroviruses and Opportunistic Infections

Conference Summaries: Day Four
Thursday, February 28, 2002

Late Breakers II (Oral Abstract Session 34)
- Switching Protease Inhibitors to Nevirapine (NVP), Efavirenz (EFA) or Abacavir (ABA): A Randomized, Multicenter, Open-Label, Simplification Trial (Abstract LB17)
  Coverage by Pablo Tebas, M.D.
Selected Highlights From Retrovirus
Coverage by Bonnie Goldman with reporting by Myles Helfand and Barbara Jungwirth

Previous Day's Sessions

Return to The Body's coverage of
The 9th Conference on Retroviruses and Opportunistic Infections.

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.